文献速递白血病淋巴瘤

活化自然杀伤细胞预测高危B/T细胞急性淋巴细胞白血病不良预后

Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
PubMed 文献 · Blood · 2021-01-01

该研究利用质谱流式、流式细胞术和计算机模拟流式细胞术,刻画高危B/T-ALL患者NK细胞的表型与功能缺陷。发现患者NK细胞细胞毒性降低但呈现活化特征,且活化细胞因子产生型NK细胞频率升高与疾病严重程度增加相关,并可独立预测不良临床结局。

要点

  • 高危B/T-ALL患者NK细胞细胞毒性降低但呈活化表型。
  • 活化细胞因子产生型NK细胞频率升高与疾病严重程度增加相关。
  • 该NK细胞频率可独立预测ALL患者不良临床结局。

核心结论

  • B/T-ALL患者NK细胞虽细胞毒性降低但呈现活化特征,活化细胞因子产生型NK细胞频率升高独立预测不良临床结局。

研究设计与样本

  • 采用质谱流式、流式细胞术和计算机模拟流式细胞术分析高危B/T-ALL患者NK细胞的表型与功能缺陷。

主要发现

  • 与正常NK细胞相比,B/T-ALL患者NK细胞细胞毒性较低但高表达CD56和CD69,产生活化NK细胞来源细胞因子并呈现钙信号。
  • NK细胞成熟为细胞毒性效应细胞的过程缺陷,使其裂解NK细胞敏感靶标的能力低于正常NK细胞。
  • ALL中NK细胞因慢性活化而耗竭。
  • 活化细胞因子产生型NK细胞频率升高与疾病严重程度增加相关,并独立预测不良临床结局。

临床怎么用

  • NK细胞谱分析可作为预测ALL患者临床结局的诊断工具。
  • 异基因NK细胞输注具有预防ALL复发的临床潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

B- and T-cell acute lymphoblastic leukemia (B/T-ALL) may be refractory or recur after therapy by suppressing host anticancer immune surveillance mediated specifically by natural killer (NK) cells. We delineated the phenotypic and functional defects in NK cells from high-risk patients with B/T-ALL using mass cytometry, flow cytometry, and in silico cytometry, with the goal of further elucidating the role of NK cells in sustaining acute lymphoblastic leukemia (ALL) regression. We found that, compared with their normal counterparts, NK cells from patients with B/T-ALL are less cytotoxic but exhibit an activated signature that is characterized by high CD56, high CD69, production of activated NK cell-origin cytokines, and calcium (Ca2+) signaling. We demonstrated that defective maturation of NK cells into cytotoxic effectors prevents NK cells from ALL from lysing NK cell-sensitive targets as efficiently as do normal NK cells. Additionally, we showed that NK cells in ALL are exhausted, which is likely caused by their chronic activation. We found that increased frequencies of activated cytokine-producing NK cells are associated with increased disease severity and independently predict poor clinical outcome in patients with ALL. Our studies highlight the benefits of developing NK cell profiling as a diagnostic tool to predict clinical outcome in patients with ALL and underscore the clinical potential of allogeneic NK cell infusions to prevent ALL recurrence.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Duault C, Kumar A, Taghi Khani A, et al. Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia. Blood. 2021. PMID: 34077953. doi:10.1182/blood.2020009871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。